External Engagements with FDA for Artificial Intelligence in Drug Development

External Engagements with FDA for Artificial Intelligence in Drug Development

Summary

To discuss the use of AI in connection with a specific development program, sponsors may request an appropriate formal meeting. Learn more.

Original reporting

Open original source

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage